BertoglioK, JamesSJ, DepreyL, BruleN, HendrenRL: Pilot study of the effect of methyl B12 treatment on behavioral and biomarker measures in children with autism. J Altern Complement Med, 16:555–160, 2010.
CaldwellPHY, EdgarD, HodsonE, CraigJC: Bedwetting and toileting problems in children. Med J Aust, 182:190–195, 2005.
5.
DeshpandeAV, CaldwellPHY: Medical management of nocturnal enuresis. Paediatr. Drugs, 14:71–77, 2012.
6.
EricksonCA, StiglerKA, CorkinsMR, PoseyDJ, FitzgeraldJF, McDougleCJ: Gastrointestinal factors in autistic disorder: A critical review. J Autism Dev Disord, 35:713–727, 2005.
7.
FriedmanB, FriedmanB, GoldmanRD: Oxybutynin for treatment of nocturnal enuresis in children. Can Fam Physician, 57:559–561, 2011.
8.
GishP, MosholderAD, TruffaM, Johann-LiangR: Spectrum of central anticholinergic adverse effects associated with oxybutynin: Comparison of pediatric and adult cases. J Pediatr, 155:432–434, 2009.
9.
GorRA, FuhrerJ, SchoberJM: A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder. J Pediatr Urol, 8:314–317, 2012.
10.
JamesSJ, CutlerP, MelnykS, JerniganS, JanakL, GaylorDW, NeubranderJA: Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutrit, 80:1611–1617, 2004.
11.
JamesSJ, MelnykS, FuchsG, ReidT, JerniganS, PavlivO, HubanksA, GaylorDW: Efficacy of methylcobalamin and folinic acid treatment on glutathione redox status in children with autism. Am J Clin Nutrit, 89:425–430, 2009.
12.
JärvelinMR: Developmental history and neurological findings in enuretic children. Dev Med Child Neurol, 31:728–736, 1989.
13.
KumarB, PrakashA, SewalRK, MedhiB, ModiM: Drug therapy in autism: A present and future perspective. Pharmacol Repo, 64:1291–1304, 2012.
MüllerD, RoehrCC, EggertP: Comparative tolerability of drug treatment for nocturnal enuresis in children. Drug Saf, 27:717–727, 2004.
16.
NaitohY, KawauchiA, YamaoY, SekiH, SohJ, YonedaK, MizutaniY, MikiT: Combination therapy with alarm and drugs for monosymptomatic nocturnal enuresis not superior to alarm monotherapy. Urology, 66:632–635, 2005.
17.
NappoS: Commentary to “A retrospective observational study of enuresis, daytime voiding symptoms, and response to medical therapy in children with attention deficit hyperactivity disorder and autism spectrum disorder.”. J Pediatr Urol, 8:318–319, 2012.
18.
NaseriM, HiradfarM: Monosymptomatic and non-monosymptomatic nocturnal enuresis: A clinical evaluation. Arch Iran Med, 15:702–706, 2012.
19.
NevéusT, von GontardA, HoebekeP, HjälmåsK, BauerS, BowerW, JørgensenTM, RittigS, WalleJV, YeungCK, DjurhuusJC: The standardization of terminology of lower urinary tract function in children and adolescents: Report from the Standardisation Committee of the International Children's Continence Society. J Urol, 176:314–324, 2006.
20.
RossignolDA: Novel and emerging treatments for autism spectrum disorders: A systematic review. Ann Clin Psychiatry, 21:213–236, 2009.
21.
RutterM, Le CouterA, LordC: ADI-R. Autism Diagnostic Interview-Revised. Los Angeles: Western Psychological Services; 2003.
22.
SchoplerE, Van BourgondienM, WellmanJ, LoveSR: CARS-2. Childhood Autism Rating Scale. Los Angeles: Western Psychological Services; 2010.
23.
SimonoffE, PicklesA, CharmanT, ChandlerS, LoucasT, BairdG: Psychiatric disorders in children with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry, 47:921–929, 2008.
24.
YucelS, KolA, GuntekinE, BaykaraM: Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis. Urology, 77:721–724, 2011.
25.
ZhaoY, SunH, MaH, ZhaoY: Comorbidities and behavioral problems in children with functional articulation disorder [in Chinese]. Zhongguo Dang Dai Er Ke Za Zhi, 11:225–228, 2009.
